biostudies-literatureUnknown23(2)Nath A<h4>Objectives</h4>Telemedicine has emerged as a promising solution for enhancing Type 2 diabetes management, which aims to reduce healthcare costs and improve patient outcomes. Despite its potential benefits for diabetes management in India, knowledge of its clinical effectiveness is scarce. This meta-analysis examines the clinical effectiveness of telemedicine versus physical consultation in managing Type 2 diabetes in India.<h4>Methods</h4>The meta-analysis adhered to the PRISMA-P guidelines and was registered with PROSPERO (CRD42023400562). PubMed and EMBASE were searched for eligible studies from 1st January 2012 to 30th June 2022. Included were studies on Type 2 diabetes patients in India comparing telemedicine (Intervention) with physical consultation (conventional) regarding effect on HbA1c changes. Risk of bias for randomised studies of Intervention (RoB-2) was used for study quality assessment.<h4>Results</h4>We found four articles that met the eligibility criteria, all reporting quantitative HbA1c change. The telemedicine interventions included video consultation, health systemcomputer-generated telephonic messages and a Video-Based Lifestyle Education Programme. Upon pooling the results from these studies, an overall analysis indicated a non-statistically significant reduction in HbA1c levels following the intervention compared to conventional treatment (pooled difference in means = -0.03, 95% CI = -0.23 to 0.17, Z = 0.30 <i>P</i> = 0.76). Likewise, there was no statistically significant difference in secondary outcomes (Body Mass Index, body weight and lipid profile) between both treatment groups.<h4>Conclusion</h4>Enhancing telemedicine approaches may hold promise in improving type 2 diabetes management in India, although the existing evidence remains inconclusive. Further research involving long-term telemedicine interventions would help to provide more substantial evidence on the clinical effectiveness of telemedicine for Type 2 diabetes management in India.<h4>Supplementary information</h4>The online version contains supplementary material available at 10.1007/s40200-024-01471-x.Journal of diabetes and metabolic disorders2095-2104https://www.ebi.ac.uk/biostudies/studies/S-EPMC11599547biostudies-literatureThe clinical effectiveness of telemedicine for managing type 2 diabetes in India: a meta-analysis of the impact of telemedicine with clinic visits.PMC11599547Thadi YPant ANath AMathew SfalseThe clinical effectiveness of telemedicine for managing type 2 diabetes in India: a meta-analysis of the impact of telemedicine with clinic visits.<h4>Objectives</h4>Telemedicine has emerged as a promising solution for enhancing Type 2 diabetes management, which aims to reduce healthcare costs and improve patient outcomes. Despite its potential benefits for diabetes management in India, knowledge of its clinical effectiveness is scarce. This meta-analysis examines the clinical effectiveness of telemedicine versus physical consultation in managing Type 2 diabetes in India.<h4>Methods</h4>The meta-analysis adhered to the PRISMA-P guidelines and was registered with PROSPERO (CRD42023400562). PubMed and EMBASE were searched for eligible studies from 1st January 2012 to 30th June 2022. Included were studies on Type 2 diabetes patients in India comparing telemedicine (Intervention) with physical consultation (conventional) regarding effect on HbA1c changes. Risk of bias for randomised studies of Intervention (RoB-2) was used for study quality assessment.<h4>Results</h4>We found four articles that met the eligibility criteria, all reporting quantitative HbA1c change. The telemedicine interventions included video consultation, health systemcomputer-generated telephonic messages and a Video-Based Lifestyle Education Programme. Upon pooling the results from these studies, an overall analysis indicated a non-statistically significant reduction in HbA1c levels following the intervention compared to conventional treatment (pooled difference in means = -0.03, 95% CI = -0.23 to 0.17, Z = 0.30 <i>P</i> = 0.76). Likewise, there was no statistically significant difference in secondary outcomes (Body Mass Index, body weight and lipid profile) between both treatment groups.<h4>Conclusion</h4>Enhancing telemedicine approaches may hold promise in improving type 2 diabetes management in India, although the existing evidence remains inconclusive. Further research involving long-term telemedicine interventions would help to provide more substantial evidence on the clinical effectiveness of telemedicine for Type 2 diabetes management in India.<h4>Supplementary information</h4>The online version contains supplementary material available at 10.1007/s40200-024-01471-x.2024-01-01T00:00:00Z2024 Dec2026-03-15T17:18:18.049Z2025-08-13T03:04:47.219ZS-EPMC115995473962154010.1007/s40200-024-01471-x